Middlesex Hospital Middlesex Hospital (2)
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Levy, Robert M
NCT05246670: PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy

Active, not recruiting
2
88
US
Palmidrol, N-Palmitoyl Ethanolamide, N-Palmitoylethanolamide, OptiPEA, Palmitoyl Ethanolamide, Palmitoylethanolamide, PEA, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment
Academic and Community Cancer Research United, National Cancer Institute (NCI)
Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
08/24
02/25
NCT05262725: Behavioral Activation for Opioid Use Disorder

Completed
N/A
21
US
Values-based Behavioral Activation
University of Minnesota
Opioid Use Disorder
02/23
02/23
NCT05288751: Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

Active, not recruiting
N/A
42
US
Contingency Management
University of Minnesota
Opioid Use Disorder, Stimulant Use Disorder
03/23
05/24

Download Options